期刊文献+

局限性前列腺癌盆腔淋巴结清扫的意义 被引量:2

下载PDF
导出
摘要 前列腺癌是男性生殖系常见的恶性肿瘤,在我国的发病率逐年上升。根治性前列腺切除术已成为目前局限性前列腺癌的主要治疗方法。而作为一个整体的盆腔淋巴结清扫,在疾病分期及预后中的意义尚未完全清楚,盆腔淋巴结清扫的范围及适应证也没有完全统一。本文拟就目前国际上对前列腺癌盆腔淋巴结清扫的意义及清扫范围的研究进展作一综述。
出处 《临床泌尿外科杂志》 2008年第6期475-478,共4页 Journal of Clinical Urology
  • 相关文献

参考文献18

  • 1Frazier H A II,Robertson J E,Paulson D F, Does radical prostatectomy in the presence of positive pelvic lymph-node enhance survival[J]? World J Urol, 1994, 12: 308-312.
  • 2Bader P, Burkard F C, Markwalder R, et al. Disease progression and survival of patients with positive after radical prostatectomy. Is there a chance for cure[J]? J Urol, 2003,169 :849-854.
  • 3Han M, Partin A W, Pound C R,et al. Long-term biochemical disease free and cancer specific survival following anatomic radical retropubic prostatectomy: the 15 year Johns Hopkins experience[J]. Urol Clin North Am,2001,28:555-565.
  • 4Allaf M E, Palapattu G S, Trock B J,et al. Anatomical extent of lymph node dissection: Impact on men with clinically localized prostate cancer[J]. J Urol, 2004, 172:1840- 1844.
  • 5Heidenreich A, Varga Z, Von Knobloch R. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis [J]. J Urol,2002,167:1681-1866.
  • 6Joslyn S A, Konety B R. Impact of extent of lymphadenectomy on survival after radical prostatectomy for prostate cancer[J]. J Urol.2006,68:121-125.
  • 7Alekseev B, Rusakov I, Vorobyev N,et al. The role of number of lymph nodes removed during radical prostatectomy and pelivic lymphadenectomy in progrprogression-free survival of prostate cancer patient[J]. Eur Urol Suppl,2007,6(2);57.
  • 8Partin A W, Kattan M W, Subong E N, et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer: a multi-institutional update[J]. JAMA,1997,277:1445-1451.
  • 9Crawford E D, Batuello J T, Snow P,et al. The use of artificial intelligence technology to predict lymph node spread in men with clinically localized prostate carcinoma[J]. Cancer,2000,88:2105-21059.
  • 10Bhatta-Dhar N, Reuther A M, Zippe C,et al. No difference in six-year biochemical failure rates with or without pelvic lymph node dissection during radical prostatectomy in low-risk patients with localized prostate cancer[J]. Urology, 2004,63 : 528- 531.

同被引文献28

  • 1Heidenreich A,Bastian P J,Bellmunt J,et al.Guidelines on prostate cancer.Uroweb 2013.http://www.uroweb.org/gls/pdf/09_Prostate_C ancer_LR.pdf.
  • 2Makarov DV,Trock BJ,Humphreys EB,et al.Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level,clinical stage,and biopsy Gleason score (Partin tables)based on cases from 2000 to 2005.Urology,2007,69:1095-1101.
  • 3Crawford ED,Batuello JT,Snow P,et al.The use of artificial intelligence technology to predict lymph node spread in men with clinically localized prostate carcinoma.Cancer,2000,88:2105-2109.
  • 4Bhatta-Dhar N,Reuther AM,Zippe C,et al.No difference in six-year biochemical failure rates with or without pelvic lymph node dissection during radical prostatectomy in low-risk patients with localized prostate cancer.Urology,2004,63:528-531.
  • 5Briganti A,Larcher A,Abdollah F,et al.Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection:the essential importance of percentage of positive cores.Eur Urol,2012,61:480-487.
  • 6Schumacher MC,Burkhard FC,Thalmann GN,et al.Is pelvic lymph node dissection necessary in patients with a serum PSA <10 ng/ml undergoing radical prostatectomy for prostate cancer?.Eur Urol,2006,50:272-279.
  • 7Kazzazi A,Djavan B.Current status of pelvic lymph node dissection in prostate cancer:the New York PLND nomogram.Can J Urol,2011,18:5585-5591.
  • 8Briganti A,Blute ML,Eastham JH,et al.Pelvic lymph node dissection in prostate cancer.Eur Urol,2009,55:1251-1265.
  • 9Briganti A,Karnes JR,Da Pozzo LF,et al.Two positive nodes represent a significant cut-off value for cancer specific survival in patients with node positive prostate cancer.A new proposal based on a two-institution experience on 703 consecutive N+ patients treated with radical prostatectomy,extended pelvic lymph node dissection and adjuvant therapy.Eur Urol, 2009, 55:261-270.
  • 10Touijer K,Fuenzalida RP,Rabbani F,et al.Extending the indications and anatomical limits of pelvic lymph node dissection for prostate cancer:improved staging or increased morbidity?.BJU Int,2011,108:372-377.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部